S517-1161 Screening compound: 3-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-{4-[(4-phenyl-4H-1,2,4-triazol-3-yl)methyl]piperidin-1-yl}propan-1-one

S517-1161 Screening compound: 3-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-{4-[(4-phenyl-4H-1,2,4-triazol-3-yl)methyl]piperidin-1-yl}propan-1-one
S517-1161 Screening compound: 3-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-{4-[(4-phenyl-4H-1,2,4-triazol-3-yl)methyl]piperidin-1-yl}propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S517-1161
3-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-{4-[(4-phenyl-4H-1,2,4-triazol-3-yl)methyl]piperidin-1-yl}propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S517-1161

Molecular Formula

C26H28N6O2 (C26 H28 N6 O2)

Compound Name

3-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-{4-[(4-phenyl-4H-1,2,4-triazol-3-yl)methyl]piperidin-1-yl}propan-1-one

IUPAC name

3-[3-(3-methylphenyl)-124-oxadiazol-5-yl]-1-{4-[(4-phenyl-4H-124-triazol-3-yl)methyl]piperidin-1-yl}propan-1-one

SMILES

Cc1cccc(-c2noc(CCC(N3CCC(Cc4nncn4-c4ccccc4)CC3)=O)n2)c1

InChI

InChI=1S/C26H28N6O2/c1-19-6-5-7-21(16-19)26-28-24(34-30-26)10-11-25(33)31-14-12-20(13-15-31)17-23-29-27-18-32(23)22-8-3-2-4-9-22/h2-9,16,18,20H,10-15,17H2,1H3

InChI Key

PQJSZSYXZBFACL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31992212

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

456.55

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.163

Distribution Coefficient, logD

4.163

Water Solubility, LogSw

-4.36

Polar Surface Area

73.222

Acid Dissociation Constant (pKa)

23.79

Base Dissociation Constant (pKb)

4.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.62

S517-1161 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with S517-1161 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S517-1161?
Check Price and Availability of S517-1161, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S517-1161 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S517-1161
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S517-1161
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S517-1161 available by request